Promore – Reports and prospectus

Interim Reports (Promore) November 22, 2019 Promore Pharma AB (publ) Delårsrapport januari – september 2019 Report (pdf)
Interim Reports (Promore) November 22, 2019 Promore Pharma AB (publ) Interim report January – September 2019 Report (pdf)
Prospectus (Promore) November 12, 2019 Företrädesemission 2019 Prospekt (pdf) Tilläggsprospekt (pdf)
Interim Reports (Promore) August 28, 2019 Promore Pharma AB (publ) Delårsrapport januari – juni 2019 Report (pdf)
Interim Reports (Promore) August 28, 2019 Promore Pharma AB (publ) Interim report January – June 2019 Report (pdf)
Interim Reports (Promore) May 21, 2019 Promore Pharma AB (publ) Delårsrapport januari – mars 2019 Report (pdf)
Interim Reports (Promore) May 21, 2019 Promore Pharma AB (publ) Interim report January – March 2019 Report (pdf)
Annual Reports (Promore) April 30, 2019 Årsredovisning 2018 Report (pdf)
Annual Reports (Promore) April 30, 2019 Annual Report 2018 Report (pdf)
Interim Reports (Promore) February 26, 2019 Promore Pharma AB (publ) Bokslutskommuniké 2018 Report (pdf)
Interim Reports (Promore) February 26, 2019 Promore Pharma AB (publ) Year-end report 2018 Report (pdf)

MESSAGE FROM THE CEO

Read what our CEO has to say about our business.

Read the CEO message

BUSINESS MODEL

The RespiraSense™ business model consists of several components that together create a complete delivery that generates attractive gross margins and recurring revenues.

Learn more about the business model

VISION

To avoid preventable respiratory failure events by transforming the standard of care in patient monitoring.

MISSION

To become the de facto standard-of-care for monitoring respiratory compromised patients in Europe and the US.